Solara Active Pharma Board Meeting Oct 16 for Q2 FY27 Results

Solara Active Pharma Sciences Ltd has announced that its Board of Directors will convene on October 16, 2026. The primary agenda item is the consideration and approval of the unaudited financial results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026. Additionally, the company has closed its trading window for designated persons from October 1, 2026, until 48 hours after the financial results announcement, in compliance with SEBI's insider trading regulations. The information will also be available on the company's website.